Davis R M Inc. cut its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 56.2% during the first quarter, Holdings Channel reports. The fund owned 5,308 shares of the pharmacy operator’s stock after selling 6,822 shares during the period. Davis R M Inc.’s holdings in Walgreens Boots Alliance were worth $441,000 as of its most recent SEC filing.
Other hedge funds have also bought and sold shares of the company. Baltimore Washington Financial Advisors Inc. bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $17,135,000. Hudock Capital Group LLC raised its stake in shares of Walgreens Boots Alliance by 0.4% in the first quarter. Hudock Capital Group LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $108,000 after buying an additional 5 shares during the period. Tarbox Group Inc. raised its stake in shares of Walgreens Boots Alliance by 288.3% in the first quarter. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator’s stock valued at $113,000 after buying an additional 1,006 shares during the period. Howe & Rusling Inc. raised its stake in shares of Walgreens Boots Alliance by 209.2% in the first quarter. Howe & Rusling Inc. now owns 1,441 shares of the pharmacy operator’s stock valued at $120,000 after buying an additional 975 shares during the period. Finally, Webster Bank N. A. raised its stake in shares of Walgreens Boots Alliance by 18.4% in the first quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock valued at $125,000 after buying an additional 235 shares during the period. 61.32% of the stock is currently owned by institutional investors.
Walgreens Boots Alliance, Inc. (WBA) opened at 76.34 on Monday. Walgreens Boots Alliance, Inc. has a one year low of $75.18 and a one year high of $88.00. The stock has a market capitalization of $82.52 billion, a price-to-earnings ratio of 19.62 and a beta of 1.20. The company has a 50-day moving average of $82.60 and a 200-day moving average of $83.69.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Wednesday, April 5th. The pharmacy operator reported $1.36 EPS for the quarter, meeting the Zacks’ consensus estimate of $1.36. Walgreens Boots Alliance had a net margin of 3.66% and a return on equity of 16.86%. The company had revenue of $29.45 billion during the quarter, compared to analysts’ expectations of $30.17 billion. During the same quarter in the prior year, the company posted $1.31 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was down 2.4% compared to the same quarter last year. On average, equities analysts forecast that Walgreens Boots Alliance, Inc. will post $4.97 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Monday, June 12th. Investors of record on Thursday, May 18th were given a dividend of $0.375 per share. The ex-dividend date of this dividend was Tuesday, May 16th. This represents a $1.50 dividend on an annualized basis and a yield of 1.96%. Walgreens Boots Alliance’s payout ratio is 38.36%.
WBA has been the subject of several research analyst reports. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Thursday, March 23rd. Deutsche Bank AG restated a “buy” rating and issued a $92.00 price objective on shares of Walgreens Boots Alliance in a report on Wednesday, March 22nd. Robert W. Baird restated an “outperform” rating and issued a $96.00 price objective on shares of Walgreens Boots Alliance in a report on Monday, March 27th. Jefferies Group LLC restated a “buy” rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a report on Thursday, April 6th. Finally, Pivotal Research initiated coverage on shares of Walgreens Boots Alliance in a report on Tuesday, April 4th. They issued a “hold” rating and a $85.00 price objective for the company. Three research analysts have rated the stock with a sell rating, three have issued a hold rating and eleven have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $90.62.
In related news, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Wednesday, May 3rd. The shares were sold at an average price of $85.89, for a total transaction of $234,995.04. Following the completion of the sale, the director now owns 21,887 shares of the company’s stock, valued at $1,879,874.43. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 13.50% of the company’s stock.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/davis-r-m-inc-has-441000-position-in-walgreens-boots-alliance-inc-wba/1939504.html
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.